High-Resolution PET Imaging for Head and Neck Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new type of PET scan that captures super-clear images of head and neck cancer (HNC). The aim is to evaluate the performance and image clarity of the new 1-mm Resolution Clinical PET camera in a real medical setting. The trial seeks individuals diagnosed with head and neck cancer who are scheduled for surgery and already have a PET/CT scan planned. Participants will undergo an additional scan with this new camera, without any extra radiation. As an unphased trial, this study provides a unique opportunity to advance imaging technology for cancer diagnosis.
Do I need to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that this PET camera is safe for imaging head and neck cancer patients?
Research has shown that PET/CT scans are commonly used for head and neck cancer and are generally considered safe. Although specific safety data for the new high-resolution PET camera is not available, it provides more detailed images without increasing radiation exposure.
Standard PET/CT scans are usually well-tolerated, indicating that this new camera should also be safe. It does not use additional radioactive material, so the risk remains the same as a regular PET/CT scan.12345Why are researchers excited about this trial?
Researchers are excited about the High-Resolution PET Imaging for Head and Neck Cancer because it offers a clearer view of tumors than standard PET/CT scans. This new PET camera boasts a 1-mm resolution, enhancing the detail and precision of cancer imaging. Unlike traditional methods, which may miss subtle changes, this high-resolution imaging can better detect and monitor head and neck cancers without adding extra radioactivity. The potential to improve diagnostic accuracy and treatment planning is a game-changer in cancer care.
What evidence suggests that this PET camera is effective for imaging head and neck cancer?
Research has shown that the 1-mm Resolution Clinical PET camera, used by participants in this trial, provides exceptionally clear images, crucial for detecting head and neck cancer. Studies have found that this detail is particularly useful for identifying small, hard-to-find growths, common in this area due to its complex structure. Early results suggest that such clear imaging can enhance the accuracy and effectiveness of cancer treatment planning. This advanced imaging technology holds promise by capturing clearer pictures, aiding doctors in making better decisions.13467
Who Is on the Research Team?
Eben Rosenthal, Ph.D
Principal Investigator
Stanford Universiy
Are You a Good Fit for This Trial?
This trial is for adults 19 years or older with a biopsy-confirmed diagnosis of head and neck cancer (HNC), who are scheduled for surgery and a PET/CT scan. It's not suitable for those with conditions that could affect their participation as judged by the study leader.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Imaging
Participants undergo a PET scan with the novel 1 mm resolution PET camera
Follow-up
Participants are monitored for safety and effectiveness after imaging
What Are the Treatments Tested in This Trial?
Interventions
- 1-mm Resolution Clinical PET camera
Trial Overview
The trial is testing a new PET camera system with 1-mm resolution to evaluate its image quality in diagnosing HNC, compared to conventional PET/CT systems, within a clinical setting.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Patients already undergoing a PET/CT scan for HNC will afterwards undergo a PET scan with the proposed device, thus no additional radioactivity is needed as part of this study.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
Emerson Collective
Collaborator
Goldman Sachs Foundation
Collaborator
Wallace H. Coulter Foundation
Collaborator
Published Research Related to This Trial
Citations
High-Resolution PET Imaging for Head and Neck Cancer
The 1-mm Resolution Clinical PET camera offers a unique advantage by providing high-resolution imaging, which can improve the accuracy of detecting and ...
Design study of a dedicated head and neck cancer PET ...
However, lesions in this region can be challenging to diagnose due to the thin, soft tissues within the neck, which require a high-resolution imaging system.
Ultra-High Spatial Resolution Clinical Positron Emission ...
This paper emphasizes progress toward achieving ≤2 mm isotropic spatial resolution in clinical PET systems, and in particular focuses on describing a 1 mm3 ...
High resolution PET/CT imaging for head and neck radiation ...
Conclusions The results from this initial investigation demonstrate the potential of a high resolution PET-CT system for planning of radiotherapy of head and ...
5.
researchgate.net
researchgate.net/publication/391526258_Ultra-High_Spatial_Resolution_Clinical_Positron_Emission_Tomography_PET_SystemsUltra-High Spatial Resolution Clinical Positron Emission ...
We are developing a 1-mm 3 resolution, high-sensitivity positron emission tomography (PET) system for loco-regional cancer imaging. The ...
Study of a 1-Millimeter Resolution Clinical Positron ...
The purpose of this study is to gain initial experience imaging HNC patient using a new PET camera, a 1mm spacial resolution.
7.
auntminnie.com
auntminnie.com/scott-williams/nuclear-medicine/pet/article/15561713/pet-imaging-general-topicsPET Imaging General Topics
The only way for clinical PET to use smaller elements and improve resolution is to improve photon sensitivity [91]. This can be accomplished by ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.